Influence of inflammation on the immunological profile of adult-derived human liver mesenchymal stromal cells and stellate cells.

[1]  J. Fung,et al.  Human Hepatic Stellate Cells Inhibit T-Cell Response Through B7-H1 Pathway , 2013, Transplantation.

[2]  C. Brantsing,et al.  The presence of local mesenchymal progenitor cells in human degenerated intervertebral discs and possibilities to influence these in vitro: a descriptive study in humans. , 2013, Stem cells and development.

[3]  I. Mannaerts,et al.  HDAC inhibitors in experimental liver and kidney fibrosis , 2013, Fibrogenesis & tissue repair.

[4]  M. Toungouz,et al.  Immune-Related Antigens, Surface Molecules and Regulatory Factors in Human-Derived Mesenchymal Stromal Cells: The Expression and Impact of Inflammatory Priming , 2012, Stem Cell Reviews and Reports.

[5]  M. Toungouz,et al.  Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes. , 2012, Immunology letters.

[6]  W-C Lee,et al.  Inhibition of allogenic T-cell cytotoxicity by hepatic stellate cell via CD4⁺ CD25⁺ Foxp3⁺ regulatory T cells in vitro. , 2012, Transplantation proceedings.

[7]  M. Toungouz,et al.  Inflammation and Toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin. , 2012, Tissue engineering. Part A.

[8]  M. Najimi,et al.  A role for autophagy during hepatic stellate cell activation. , 2012, Journal of hepatology.

[9]  G. Lepperdinger.  Inflammation and mesenchymal stem cell aging , 2011, Current opinion in immunology.

[10]  A. Durrbach,et al.  Long-Lasting Inhibitory Effects of Fetal Liver Mesenchymal Stem Cells on T-Lymphocyte Proliferation , 2011, PloS one.

[11]  J. Levitsky.  Operational tolerance: Past lessons and future prospects , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[12]  R. Henschler,et al.  Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase , 2011, Leukemia.

[13]  M. Parola,et al.  Stem and progenitor cells in liver regeneration and repair. , 2011, Cytotherapy.

[14]  S. Friedman,et al.  Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis , 2010, Fibrogenesis & tissue repair.

[15]  M. Toungouz,et al.  Modulated expression of adhesion molecules and galectin-1: role during mesenchymal stromal cell immunoregulatory functions. , 2010, Experimental hematology.

[16]  J. Briones,et al.  T-Cell Costimulatory Molecules in Acute-Graft-Versus Host Disease: Therapeutic Implications , 2010, Bone marrow research.

[17]  M. Toungouz,et al.  Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor. , 2010, Tissue engineering. Part A.

[18]  S. Akira,et al.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors , 2010, Nature Immunology.

[19]  Katie C. Russell,et al.  In Vitro High‐Capacity Assay to Quantify the Clonal Heterogeneity in Trilineage Potential of Mesenchymal Stem Cells Reveals a Complex Hierarchy of Lineage Commitment , 2010, Stem cells.

[20]  P. Martiat,et al.  Inflammation modifies the pattern and the function of Toll-like receptors expressed by human mesenchymal stromal cells. , 2010, Human immunology.

[21]  V. Rogiers,et al.  Chronic administration of valproic acid inhibits activation of mouse hepatic stellate cells in vitro and in vivo , 2010, Hepatology.

[22]  R. Zhao,et al.  Inhibition of hepatic stellate cells proliferation by mesenchymal stem cells and the possible mechanisms , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

[23]  Mengji Lu,et al.  Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication. , 2009, Journal of hepatology.

[24]  J. Fung,et al.  Mechanistic insights into immunomodulation by hepatic stellate cells in mice: A critical role of interferon‐γ signaling , 2009, Hepatology.

[25]  L. Moretta,et al.  MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. , 2009, Blood.

[26]  R. Romieu-Mourez,et al.  Cytokine Modulation of TLR Expression and Activation in Mesenchymal Stromal Cells Leads to a Proinflammatory Phenotype1 , 2009, The Journal of Immunology.

[27]  F. Lanza,et al.  A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs , 2009, Cytometry. Part B, Clinical cytometry.

[28]  Seong Who Kim,et al.  Down-regulation of CD105 is associated with multi-lineage differentiation in human umbilical cord blood-derived mesenchymal stem cells. , 2009, Biochemical and biophysical research communications.

[29]  Olivia T. Abar,et al.  Functional linkage of cirrhosis‐predictive single nucleotide polymorphisms of toll‐like receptor 4 to hepatic stellate cell responses , 2009, Hepatology.

[30]  S. McTaggart,et al.  Immunosuppression by mesenchymal stromal cells: from culture to clinic. , 2008, Experimental hematology.

[31]  L. Cosmi,et al.  Toll‐Like Receptors 3 and 4 Are Expressed by Human Bone Marrow‐Derived Mesenchymal Stem Cells and Can Inhibit Their T‐Cell Modulatory Activity by Impairing Notch Signaling , 2008, Stem cells.

[32]  H. Li,et al.  The role of toll-like receptors 2 and 4 in acute allograft rejection after liver transplantation. , 2007, Transplantation proceedings.

[33]  Yosuke Osawa,et al.  TLR4 enhances TGF-β signaling and hepatic fibrosis , 2007, Nature Medicine.

[34]  Wenda Gao,et al.  OX40 costimulation turns off Foxp3+ Tregs. , 2007, Blood.

[35]  C. Sempoux,et al.  Adult-Derived Human Liver Mesenchymal-Like Cells as a Potential Progenitor Reservoir of Hepatocytes? , 2007, Cell transplantation.

[36]  L. Fouillard,et al.  Immunosuppressive Effects of Mesenchymal Stem Cells: Involvement of HLA-G , 2007, Transplantation.

[37]  M. Najimi,et al.  Sustained engraftment and tissue enzyme activity after liver cell transplantation for argininosuccinate lyase deficiency. , 2006, Gastroenterology.

[38]  L. Moretta,et al.  Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. , 2006, Blood.

[39]  Sergio Romagnani,et al.  Role for Interferon‐γ in the Immunomodulatory Activity of Human Bone Marrow Mesenchymal Stem Cells , 2006 .

[40]  R. Sun,et al.  Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. , 2006, Gastroenterology.

[41]  S. Perez,et al.  Interactions Between Human Mesenchymal Stem Cells and Natural Killer Cells , 2006, Stem cells.

[42]  M. Gobbi,et al.  Interaction between Human NK Cells and Bone Marrow Stromal Cells Induces NK Cell Triggering: Role of NKp30 and NKG2D Receptors1 , 2005, The Journal of Immunology.

[43]  Yi Zhang,et al.  Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. , 2005, Blood.

[44]  D. Mevorach,et al.  Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. , 2005, Blood.

[45]  M. Pittenger,et al.  Human mesenchymal stem cells modulate allogeneic immune cell responses. , 2005, Blood.

[46]  R. Zhao,et al.  Systemic Infusion of FLK1+ Mesenchymal Stem Cells Ameliorate Carbon Tetrachloride-Induced Liver Fibrosis in Mice , 2004, Transplantation.

[47]  K. Blanc.  Immunomodulatory effects of fetal and adult mesenchymal stem cells. , 2003 .

[48]  O. Ringdén,et al.  Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells , 2003, Transplantation.

[49]  M. Weller,et al.  Human muscle cells express a B7‐related molecule, B7‐H1, with strong negative immune regulatory potential: a novel mechanism of counterbalancing the immune attack in idiopathic inflammatory myopathies , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[50]  O. Ringdén,et al.  HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. , 2003, Experimental hematology.

[51]  A. Moser,et al.  Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up. , 2003, Transplantation.

[52]  Elizabeth Simpson,et al.  Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. , 2003, Blood.

[53]  Mitsuru Sato,et al.  Hepatic stellate cells: unique characteristics in cell biology and phenotype. , 2003, Cell structure and function.

[54]  O. Ringdén,et al.  Mesenchymal Stem Cells Inhibit and Stimulate Mixed Lymphocyte Cultures and Mitogenic Responses Independently of the Major Histocompatibility Complex , 2003, Scandinavian journal of immunology.

[55]  R. Gorczynski,et al.  The Same Immunoregulatory Molecules Contribute to Successful Pregnancy and Transplantation , 2002, American journal of reproductive immunology.

[56]  C. Carlo-Stella,et al.  Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. , 2002, Blood.

[57]  A. Granato,et al.  Hepatocyte transplantation as a treatment for glycogen storage disease type 1a , 2002, The Lancet.

[58]  F. Marra,et al.  Cytokine Receptors and Signaling in Hepatic Stellate Cells , 2001, Seminars in liver disease.

[59]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[60]  R. Fisher,et al.  Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. , 1997, Transplantation.

[61]  M. Toungouz,et al.  Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: Combined comparison of adipose tissue, Wharton's Jelly and bone marrow sources. , 2010, Cellular immunology.

[62]  J. Mei,et al.  The quest for liver progenitor cells: a practical point of view. , 2010, Journal of hepatology.

[63]  S. Friedman.  Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. , 2008, Physiological reviews.

[64]  F. Benvenuto,et al.  Human mesenchymal stem cells modulate B-cell functions. , 2006, Blood.

[65]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[66]  C. Nathan,et al.  Putting the brakes on innate immunity: a regulatory role for CD200? , 2001, Nature Immunology.